|
1
|
Sinaii N, Cleary SD, Ballweg ML, Nieman LK
and Stratton P: High rates of autoimmune and endocrine disorders,
fibromyalgia, chronic fatigue syndrome and atopic diseases among
women with endometriosis: A survey analysis. Hum Reprod.
17:2715–2724. 2002.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kvaskoff M, Mu F, Terry KL, Harris HR,
Poole EM, Farland L and Missmer SA: Endometriosis: A high-risk
population for major chronic diseases? Hum Reprod Update.
21:500–516. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Rafi U, Ahmad S, Bokhari SS, Iqbal MA, Zia
A, Khan MA and Roohi N: Association of inflammatory
markers/cytokines with cardiovascular risk manifestation in
patients with endometriosis. Mediators Inflamm.
2021(3425560)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Surrey ES, Soliman AM, Johnson SJ, Davis
M, Castelli-Haley J and Snabes MC: Risk of developing comorbidities
among women with endometriosis: A retrospective matched cohort
study. J Womens Health (Larchmt). 27:1114–1123. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Harris HR, Korkes KMN, Li T, Kvaskoff M,
Cho E, Carvalho LF, Qureshi AA, Abrao M and Missmer SA:
Endometriosis, psoriasis and psoriatic arthritis: A prospective
cohort study. Am J Epidemiol. 191:1050–1060. 2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lebovic DI, Mueller MD and Taylor RN:
Immunobiology of endometriosis. Fertil Steril. 75:1–10.
2001.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Treloar SA, O'Connor DT, O'Connor VM and
Martin NG: Genetic influences on endometriosis in an Australian
twin sample. sueT@qimr.edu.au. Fertil Steril. 71:701–710.
1999.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Giudice LC and Kao LC: Endometriosis.
Lancet. 364:1789–1799. 2004.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bulun SE: Endometriosis. N Engl J Med.
360:268–279. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Symons LK, Miller JE, Kay VR, Marks RM,
Liblik K, Koti M and Tayade C: The immunopathophysiology of
endometriosis. Trends Mol Med. 24:748–762. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zondervan KT, Becker CM, Koga K, Missmer
SA, Taylor RN and Viganò P: Endometriosis. Nat Rev Dis Primers.
4(9)2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sourial S, Tempest N and Hapangama DK:
Theories on the pathogenesis of endometriosis. Int J Reprod Med.
2014(179515)2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sampson JA: Peritoneal endometriosis due
to menstrual dissemination of endometrial tissue into the
peritoneal cavity. Am J Obstet Gynecol. 14:422–469. 1927.
|
|
14
|
Vercellini P, Viganò P, Somigliana E and
Fedele L: Endometriosis: Pathogenesis and treatment. Nat Rev
Endocrinol. 10:261–275. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Szymanowski K: Apoptosis pattern in human
endometrium in women with pelvic endometriosis. Eur J Obstet
Gynecol Reprod Biol. 132:107–110. 2007.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Dmowski WP, Gebel HM and Braun DP: The
role of cell-mediated immunity in pathogenesis of endometriosis.
Acta Obstet Gynecol Scand Suppl. 159:7–14. 1994.PubMed/NCBI
|
|
17
|
Siristatidis C, Nissotakis C, Chrelias C,
Iacovidou H and Salamalekis E: Immunological factors and their role
in the genesis and development of endometriosis. J Obstet Gynaecol
Res. 32:162–170. 2006.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zervou MI, Tarlatzis BC, Grimbizis GF,
Spandidos DA, Niewold TB and Goulielmos GN: Association of
endometriosis with Sjögren's syndrome: Genetic insights (review).
Int J Mol Med. 53(20)2024.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Eisenberg VH, Zolti M and Soriano D: Is
there an association between autoimmunity and endometriosis?
Autoimmun Rev. 11:806–814. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Matarese G, De Placido G, Nikas Y and
Alviggi C: Pathogenesis of endometriosis: Natural immunity
dysfunction or autoimmune disease? Trends Mol Med. 9:223–228.
2003.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Iborra A, Palacio JR, Ulcova-Gallova Z and
Martínez P: Autoimmune response in women with endometriosis. Am J
Reprod Immunol. 44:236–241. 2000.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Nothnick WB: Treating endometriosis as an
autoimmune disease. Fertil Steril. 76:223–230. 2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Singh R, Koppu S, Perche PO and Feldman
SR: The cytokine mediated molecular pathophysiology of psoriasis
and its clinical implications. Int J Mol Sci.
22(12793)2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Grän F, Kerstan A, Serfling E, Goebeler M
and Muhammad K: Current developments in the immunology of
psoriasis. Yale J Biol Med. 93(97)2020.PubMed/NCBI
|
|
25
|
Elder JT, Bruce AT, Gudjonsson JE,
Johnston A, Stuart PE, Tejasvi T, Voorhees JJ, Abecasis GR and Nair
RP: Molecular dissection of psoriasis: Integrating genetics and
biology. J Investig Dermatol. 130:1213–1226. 2010.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lebwohl M: Psoriasis. Lancet.
361:1197–1204. 2003.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bronckers IM, Paller AS, van Geel MJ, van
de Kerkhof PC and Seyger MM: Psoriasis in children and adolescents:
Diagnosis, management and comorbidities. Paediatr Drugs.
17:373–384. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Raychaudhuri SK, Maverakis E and
Raychaudhuri SP: Diagnosis and classification of psoriasis.
Autoimmun Rev. 13:490–495. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Al-Mazeedi K, El-Shazly M and Al-Ajmi HS:
Impact of psoriasis on quality of life in Kuwait. Int J Dermatol.
45:418–424. 2006.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Campalani E and Barker JNWN: The clinical
genetics of psoriasis. Curr Genomics. 6:51–60. 2005.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Langier S, Sade K and Kivity S: Regulatory
T cells: The suppressor arm of the immune system. Autoimmun Rev.
10:112–115. 2010.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Owczarczyk-Saczonek A, Czerwińska J and
Placek W: The role of regulatory T cells and anti-inflammatory
cytokines in psoriasis. Acta Dermatovenerol Alp Pannonica Adriat.
27:17–23. 2018.PubMed/NCBI
|
|
33
|
Nussbaum L, Chen YL and Ogg GS: Role of
regulatory T cells in psoriasis pathogenesis and treatment. Br J
Dermatol. 184:14–24. 2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Deng Y, Chang C and Lu Q: The inflammatory
response in psoriasis: A comprehensive review. Clin Rev Allergy
Immunol. 50:377–389. 2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Nedoszytko B, Lange M, Sokołowska-Wojdyło
M, Renke J, Trzonkowski P, Sobjanek M, Szczerkowska-Dobosz A,
Niedoszytko M, Górska A, Romantowski J, et al: The role of
regulatory T cells and genes involved in their differentiation in
pathogenesis of selected inflammatory and neoplastic skin diseases.
Part II: The Treg role in skin diseases pathogenesis. Postepy
Dermatol Alergol. 34:405–417. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Dasgupta A and Saxena R: Regulatory T
cells: A review. Natl Med J India. 25:341–351. 2012.PubMed/NCBI
|
|
37
|
Lowes MA, Bowcock AM and Krueger JG:
Pathogenesis and therapy of psoriasis. Nature. 445:866–873.
2007.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Gladman DD, Antoni C, Mease P, Clegg DO
and Nash P: Psoriatic arthritis: Epidemiology, clinical features,
course, and outcome. Ann Rheum Dis. 64 (Suppl 2):ii14–ii7.
2005.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ocampo DV and Gladman D: Psoriatic
arthritis. F1000Res. 8(1665)2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Rahman P and Elder JT: Genetic
epidemiology of psoriasis and psoriatic arthritis. Ann Rheum Dis.
64 (Suppl 2):S37–S41. 2005.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Zervou MI, Vlachakis D, Papageorgiou L,
Eliopoulos E and Goulielmos GN: Increased risk of rheumatoid
arthritis in patients with endometriosis: Genetic aspects.
Rheumatology (Oxford). 61:4252–4262. 2022.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Rahmioglu N, Nyholt DR, Morris AP, Missmer
SA, Montgomery GW and Zondervan KT: Genetic variants underlying
risk of endometriosis: Insights from meta-analysis of eight
genome-wide association and replication datasets. Hum Reprod
Update. 20:702–716. 2014.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Sapkota Y, Steinthorsdottir V, Morris AP,
Fassbender A, Rahmioglu N, De Vivo I, Buring JE, Zhang F, Edwards
TL, Jones S, et al: Meta-analysis identifies five novel loci
associated with endometriosis highlighting key genes involved in
hormone metabolism. Nat Commun. 8(15539)2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Rahmioglu N, Mortlock S, Ghiasi M, Møller
PL, Stefansdottir L, Galarneau G, Turman C, Danning R, Law MH,
Sapkota Y, et al: The genetic basis of endometriosis and
comorbidity with other pain and inflammatory conditions. Nat Genet.
55:423–436. 2023.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Saha R, Pettersson HJ, Svedberg P,
Olovsson M, Bergqvist A, Marions L, Tornvall P and Kuja-Halkola R:
Heritability of endometriosis. Fertil Steril. 104:947–952.
2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Lee SH, Harold D and Nyholt DR: ANZGene
Consortium; International Endogene Consortium; Genetic and
Environmental Risk for Alzheimer's disease Consortium. Goddard ME,
Zondervan KT, Williams J, Montgomery GW, et al: Estimation and
partitioning of polygenic variation captured by common SNPs for
Alzheimer's disease, multiple sclerosis and endometriosis. Hum Mol
Genet. 22:832–841. 2013.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Nyholt DR, Low SK, Anderson CA, Painter
JN, Uno S, Morris AP, MacGregor S, Gordon SD, Henders AK, Martin
NG, et al: Genome-wide association meta-analysis identifies new
endometriosis risk loci. Nat Genet. 44:1355–1359. 2012.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Kobayashi H, Imanaka S, Nakamura H and
Tsuji A: Understanding the role of epigenomic, genomic and genetic
alterations in the development of endometriosis (review). Mol Med
Rep. 9:1483–1505. 2014.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Vassilopoulou L, Matalliotakis M, Zervou
MI, Matalliotaki C, Krithinakis K, Matalliotakis I, Spandidos DA
and Goulielmos GN: Defining the genetic profile of endometriosis.
Exp Therap Med. 17:3267–3281. 2019.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Albertsen HM, Matalliotaki C,
Matalliotakis M, Zervou MI, Matalliotakis I, Spandidos DA, Chettier
R, Ward K and Goulielmos GN: Whole exome sequencing identifies
hemizygous deletions in the UGT2B28 and USP17L2 genes in a
three-generation family with endometriosis. Mol Med Rep.
19:1716–1720. 2019.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Goulielmos GN, Matalliotakis M,
Matalliotaki C, Eliopoulos E, Matalliotakis I and Zervou MI:
Endometriosis research in the-omics era. Gene.
741(144545)2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Vazgiourakis VM, Zervou MI, Papageorgiou
L, Chaniotis D, Spandidos DA, Vlachakis D, Eliopoulos E and
Goulielmos GN: Association of endometriosis with cardiovascular
disease: Genetic aspects (review). Int J Mol Med.
51(29)2023.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Elder JT, Nair RP, Guo SW, Henseler T,
Christophers E and Voorhees JJ: The genetics of psoriasis. Arch
Dermatol. 130:216–224. 1994.PubMed/NCBI
|
|
54
|
Brandrup F, Hauge M, Henningen K and
Eriksen B: Psoriasis in an unselected series of twins. Arch
Dermatol. 114:874–878. 1978.PubMed/NCBI
|
|
55
|
Tagami H: Triggering factors. Clin
Dermatol. 15:677–685. 1997.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Farber EM and Nall ML: The natural history
of psoriasis in 5,600 patients. Dermatologica. 148:1–18.
1974.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Stuart PE, Nair RP, Tsoi LC, Tejasvi T,
Das S, Kang HM, Ellinghaus E, Chandran V, Callis-Duffin K, Ike R,
et al: Genome-wide association analysis of psoriatic arthritis and
cutaneous psoriasis reveals differences in their genetic
architecture. Am J Hum Genet. 97:816–836. 2015.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Osmola-Mańkowska A, Teresiak-Mikołajczak
E, Skrzypczak-Zielińska M and Adamski Z: Genetic polymorphism in
psoriasis and its meaning for the treatment efficacy in the future.
Postepy Dermatol Alergol. 35:331–337. 2018.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Singh S, Pradhan D, Puri P, Ramesh V,
Aggarwal S, Nayek A and Jain AK: Genomic alterations driving
psoriasis pathogenesis. Gene. 683:61–71. 2019.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Prinz JC: Autoimmune aspects of psoriasis:
Heritability and autoantigens. Autoimmun Rev. 16:970–979.
2017.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Sun LD, Cheng H, Wang ZX, Zhang AP, Wang
PG, Xu JH, Zhu QX, Zhou HS, Ellinghaus E, Zhang FR, et al:
Association analyses identify six new psoriasis susceptibility loci
in the Chinese population. Nat Genet. 42:1005–1009. 2010.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Bieber T and Nestle F (eds): Personalized
treatment options in dermatology. Springer-Verlag, Berlin
Heidelberg, pp86-87, 2015.
|
|
63
|
Liu Y, Helms C, Liao W, Zaba LC, Duan S,
Gardner J, Wise C, Miner A, Malloy MJ, Pullinger CR, et al: A
genome-wide association study of psoriasis and psoriatic arthritis
identifies new disease loci. PLoS Genet. 4(e1000041)2008.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Patel HA, Revankar RR, Pedroza ST, Graham
S and Feldman SR: The genetic susceptibility to psoriasis and the
relationship of linked genes to our treatment options. Int J Mol
Sci. 24(12310)2023.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Karason A, Love TJ and Gudbjornsson B: A
strong heritability of psoriatic arthritis over four
generations-the Reykjavik psoriatic arthritis study. Rheumatology
(Oxford). 48:1424–1428. 2009.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Eder L, Chandran V, Pellet F,
Shanmugarajah S, Rosen CF, Bull SB and Gladman DD: Human leucocyte
antigen risk alleles for psoriatic arthritis among patients with
psoriasis. Ann Rheum Dis. 71:50–55. 2012.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Bowes J, Budu-Aggrey A, Huffmeier U, Uebe
S, Steel K, Hebert HL, Wallace C, Massey J, Bruce IN, Bluett J, et
al: Dense genotyping of immune-related susceptibility loci reveals
new insights into the genetics of psoriatic arthritis. Nat Commun.
6(6046)2015.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Bowes J, Loehr S, Budu-Aggrey A, Uebe S,
Bruce IN, Feletar M, Marzo-Ortega H, Helliwell P, Ryan AW, Kane D,
et al: PTPN22 is associated with susceptibility to psoriatic
arthritis but not psoriasis: Evidence for a further PsA-specific
risk locus. Ann Rheum Dis. 74:1882–1885. 2015.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Chandran V, Bull SB, Pellett FJ, Ayearst
R, Pollock RA and Gladman DD: Killer-cell immunoglobulin-like
receptor gene polymorphisms and susceptibility to psoriatic
arthritis. Rheumatology (Oxford). 53:233–239. 2014.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Bowes J, Eyre S, Flynn E, Ho P, Salah S,
Warren RB, Marzo-Ortega H, Coates L, McManus R, Ryan AW, et al:
Evidence to support IL-13 as a risk locus for psoriatic arthritis
but not psoriasis vulgaris. Ann Rheum Dis. 70:1016–1019.
2011.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Yang Q, Liu H, Qu L, Fu X, Yu Y, Yu G,
Tian H, Yu Y, Sun D, Peng J, et al: Investigation of 20 non-HLA
(human leucocyte antigen) psoriasis susceptibility loci in Chinese
patients with psoriatic arthritis and psoriasis vulgaris. Br J
Dermatol. 168:1060–1065. 2013.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Morales-Zambrano R, Bautista-Herrera LA,
De la Cruz-Mosso U, Villanueva-Quintero GD, Padilla-Gutiérrez JR,
Valle Y, Parra-Rojas I, Rangel-Villalobos H, Gutiérrez-Ureña SR and
Muñoz-Valle JF: Macrophage migration inhibitory factor (MIF)
promoter polymorphisms (-794 CATT5-8 and -173 G>C): Association
with MIF and TNFα in psoriatic arthritis. Int J Clin Exp Med.
7:2605–2614. 2014.PubMed/NCBI
|
|
73
|
Taylor HS, Kotlyar AM and Flores VA:
Endometriosis is a chronic systemic disease: Clinical challenges
and novel innovations. Lancet. 397:839–852. 2021.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Mier-Cabrera J, Cruz-Orozco O, de la
Jara-Díaz J, Galicia-Castillo O, Buenrostro-Jáuregui M,
Parra-Carriedo A and Hernández-Guerrero C: Polymorphisms of
TNF-alpha (-308), IL-1beta (+ 3954) and IL1-Ra (VNTR) are
associated to severe stage of endometriosis in Mexican women: A
case control study. BMC Womens Health. 22(356)2022.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Höhler T, Kruger A, Schneider PM, Schopf
RE, Knop J, Rittner C, Meyer zum Büschenfelde KH and Märker-Hermann
E: A TNF-alpha promoter polymorphism is associated with juvenile
onset psoriasis and psoriatic arthritis. J Invest Dermatol.
109:562–565. 1997.PubMed/NCBI View Article : Google Scholar
|
|
76
|
André GM, Barbosa CP, Teles JS, Vilarino
FL, Christofolini DM and Bianco B: Analysis of FOXP3 polymorphisms
in infertile women with and without endometriosis. Fertil Steril.
95:2223–2227. 2011.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Song QH, Shen Z, Xing XJ, Yin R, Wu YZ,
You Y, Guo H, Chen L, Hao F and Bai Y: An association study of
single nucleotide polymorphisms of the FOXP3 intron-1 and the risk
of psoriasis vulgaris. Indian J Biochem Biophys. 49:25–35.
2012.PubMed/NCBI
|
|
78
|
Sundqvist J, Falconer H, Seddighzadeh M,
Vodolazkaia A, Fassbender A, Kyama C, Bokor A, Stephansson O,
Padyukov L, Gemzell-Danielsson K and D'Hooghe TM: Endometriosis and
autoimmune disease: Association of susceptibility to
moderate/severe endometriosis with CCL21 and HLA-DRB1. Fertil
Steril. 95:437–440. 2011.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Juo SHH, Wu R, Lin CS, Wu MT, Lee JN and
Tsai EM: A functional promoter polymorphism in interleukin-10 gene
influences susceptibility to endometriosis. Fertil Steril.
92:1228–1233. 2009.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Indhumathi S, Rajappa M, Chandrashekar L,
Ananthanarayanan PH, Thappa DM and Negi VS: T helper-2
cytokine/regulatory T-cell gene polymorphisms and their relation
with risk of psoriasis in a South Indian Tamil cohort. Hum Immunol.
78:209–215. 2017.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Delli Carpini G, Giannella L, Di Giuseppe
J, Montik N, Montanari M, Fichera M, Crescenzi D, Marzocchini C,
Meccariello ML, Di Biase D, et al: Homozygous C677T
methylenetetrahydrofolate reductase (MTHFR) polymorphism as a risk
factor for endometriosis: A retrospective case-control study. Int J
Mol Sci. 24(15404)2023.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Asefi M, Vaisi-Raygani A, Khodarahmi R,
Nemati H, Rahimi Z, Vaisi-Raygani H, Tavilani H and Pourmotabbed T:
Methylentetrahydrofolatereductase (rs1801133) polymorphism and
psoriasis: Contribution to oxidative stress, lipid peroxidation and
correlation with vascular adhesion protein 1, preliminary report. J
Eur Acad Dermatol Venereol. 28:1192–1198. 2014.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Zhu J, Wang Z, Tao L, Han L, Huang Q, Fang
X, Yang K, Huang G, Zheng Z, Yawalkar N, et al: MTHFR gene
polymorphism association with psoriatic arthritis risk and the
efficacy and hepatotoxicity of methotrexate in psoriasis. Front Med
(Lausanne). 9(869912)2022.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Bianco B, Fernandes RFM, Trevisan CM,
Christofolini DM, Sanz-Lomana CM, de Bernabe JV and Barbosa CP:
Influence of STAT4 gene polymorphisms in the pathogenesis of
endometriosis. Ann Hum Genet. 83:249–255. 2019.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Zervou MI, Goulielmos GN, Castro-Giner F,
Tosca AD and Krueger-Krasagakis S: STAT4 gene polymorphism is
associated with psoriasis in the genetically homogeneous population
of Crete, Greece. Hum Immunol. 70:738–741. 2009.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Xu S, Wu W, Sun H, Lu J, Yuan B, Xia Y, De
Moor B, Marchal K, Wang X, Xu P and Cheng W: Association of the
vascular endothelial growth factor gene polymorphisms (-460C/T,
+405G/C and +936T/C) with endometriosis: A meta-analysis. Ann Hum
Genet. 76:464–471. 2012.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Sudhesan A, Rajappa M, Chandrashekar L,
Ananthanarayanan PH, Thappa DM, Satheesh S and Chandrasekaran A:
Vascular endothelial growth factor (VEGF) gene polymorphisms
(rs699947, rs833061, and rs2010963) and psoriatic risk in South
Indian Tamils. Hum Immunol. 78:657–663. 2017.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Zablotna M, Sobjanek M, Nedoszytko B,
Lange M, Kozicka D, Glen J and Roszkiewicz J: Association of
psoriasis with the VEGF gene polymorphism in the northern Polish
population. J Eur Acad Dermatol Venereol. 27:319–323.
2013.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Lee YH and Song GG: Vascular endothelial
growth factor gene polymorphisms and psoriasis susceptibility: A
meta-analysis. Genet Mol Res. 14:14396–14405. 2015.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Perini JA, Cardoso JV, Berardo PT,
Vianna-Jorge R, Nasciutti LE, Bellodi-Privato M, Machado DE and
Abrão MS: Role of vascular endothelial growth factor polymorphisms
(-2578C>A, -460 T>C, -1154G>A, +405G>C and +936C>T)
in endometriosis: A case-control study with Brazilians. BMC Womens
Health. 14(117)2014.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Qi M, Huang X, Zhou L and Zhang J: Four
polymorphisms of VEGF (+405C>G, -460T>C, -2578C>A, and
-1154G>A) in susceptibility to psoriasis: a meta-analysis. DNA
Cell Biol. 33:234–244. 2014.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Hata Y, Nakaoka H, Yoshihara K, Adachi S,
Haino K, Yamaguchi M, Nishikawa N, Kashima K, Yahata T, Tajima A,
et al: A nonsynonymous variant of IL1A is associated with
endometriosis in Japanese population. J Hum Genet. 58:517–520.
2013.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Sapkota Y, Low SK, Attia J, Gordon SD,
Henders AK, Holliday EG, MacGregor S, Martin NG, McEvoy M, Morris
AP, et al: Association between endometriosis and the interleukin 1A
(IL1A) locus. Hum Reprod. 30:239–248. 2015.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Chekini Z, Shahhoseini M, Aflatoonian R
and Afsharian P: The relationship between functional promoter
variants of macrophage migration inhibitory factor and
endometriosis. Cell J. 22:450–456. 2021.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Gomes FMCS, Bianco B, Teles JS,
Christofolini DM, de Souza AMB, Guedes AD and Barbosa CP: PTPN22
C1858T polymorphism in women with endometriosis. Am J Reprod
Immunol. 63:227–232. 2010.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Butt C, Peddle L, Greenwood C, Hamilton S,
Gladman D and Rahman P: Association of functional variants of
PTPN22 and tp53 in psoriatic arthritis: A case-control study.
Arthritis Res Ther. 8(R27)2006.PubMed/NCBI View
Article : Google Scholar
|
|
97
|
Dunham I, Sargent CA, Trowsdale J and
Campbell RD: Molecular mapping of the human major
histocompatibility complex by pulsed-field gel electrophoresis.
Proc Natl Acad Sci USA. 84:7237–7241. 1987.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Kalliolias GD and Ivashkiv LB: TNF
biology, pathogenic mechanisms and emerging therapeutic strategies.
Nat Rev Rheumatol. 12:49–62. 2016.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Abutorabi R, Baradaran A, Mostafavi F,
Zarrin Y and Mardanian F: Evaluation of tumor necrosis factor alpha
polymorphism frequencies in endometriosis. Int J Fertil Steril.
9:329–337. 2015.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Queiro R, Tejón P, Alonso S and Coto P:
Age at disease onset: A key factor for understanding psoriatic
disease. Rheumatology (Oxford). 53:1178–1185. 2014.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Herrera F, Gutiérrez L, Salazar Alcalá E,
Balbas O and Fernández Mestre M: Role of TNF-Alpha and IL10 genes
in the development and clinical manifestations of psoriatic
arthritis. Rev Colomb Reumatol. 25:9–15. 2018.
|
|
102
|
Wilson AG, Symons JA, McDowell TL,
McDevitt HO and Duff GW: Effects of a polymorphism in the human
tumor necrosis factor alpha promoter on transcriptional activation.
Proc Natl Acad Sci USA. 94:3195–3199. 1997.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Gupta V, Gupta A, Jafar T, Gupta V,
Agrawal S, Srivastava N, Kumar S, Singh AK, Natu SM, Agarwal CG and
Agarwal GG: Association of TNF-α promoter gene G-308A polymorphism
with metabolic syndrome, insulin resistance, serum TNF-α and leptin
levels in Indian adult women. Cytokine. 57:32–36. 2012.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Yang ZC, Xu F, Tang M and Xiong X:
Association between TNF-α promoter-308 A/G polymorphism and
systemic lupus erythematosus susceptibility: A case-control study
and meta-analysis. Scand J Immunol. 85:197–210. 2017.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Keenan JA, Chen TT, Chadwell NL, Torry DS
and Caudle MR: IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid
and macrophage-conditioned media of women with endometriosis. Am J
Reprod Immunol. 34:381–385. 1995.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Braun DP, Gebel H, House R, Rana N and
Dmowski NP: Spontaneous and induced synthesis of cytokines by
peripheral blood monocytes in patients with endometriosis. Fertil
Steril. 65:1125–1129. 1996.PubMed/NCBI
|
|
107
|
Eisermann J, Gast M, Pineda J, Odem RR and
Collins JL: Tumor necrosis factor in peritoneal fluid of women
undergoing laparoscopic surgery. Fertil Steril. 50:573–579.
1988.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Bischoff F and Simpson JL: Genetic basis
of endometriosis. Ann N Y Acad Sci. 1034:284–299. 2004.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Ettehadi P, Greaves MW, Wallach D, Aderka
D and Camp RD: Elevated tumour necrosis factor-alpha (TNF-alpha)
biological activity in psoriatic skin lesions. Clin Exp Immunol.
96:146–151. 1994.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Kristensen M, Chu CQ, Eedy DJ, Feldmann M,
Brennan FM and Breathnach SM: Localization of tumour necrosis
factor-alpha (TNF-alpha) and its receptors in normal and psoriatic
skin: Epidermal cells express the 55-kD but not the 75-kD TNF
receptor. Clin Exp Immunol. 94:354–362. 1993.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Bonifati C, Carducci M, Cordiali Fei P,
Trento E, Sacerdoti G, Fazio M and Ameglio F: Correlated increases
of tumour necrosis factor-alpha, interleukin-6 and granulocyte
monocyte-colony stimulating factor levels in suction blister fluids
and sera of psoriatic patients-relationships with disease severity.
Clin Exp Dermatol. 19:383–387. 1994.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Heydarinejad P, Gholijani N, Habibagahi Z,
Malekmakan MR and Amirghofran Z: FOXP3 gene variants in patients
with systemic lupus erythematosus: Association with disease
susceptibility in men and relationship with abortion in women. Iran
J Immunol. 19:172–183. 2022.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Yagi H, Nomura T, Nakamura K, Yamazaki S,
Kitawaki T, Hori S, Maeda M, Onodera M, Uchiyama T, Fujii S, et al:
Crucial role of FOXP3 in the development and function of human
CD25+CD4+ regulatory T cells. Int Immunol. 16:1643–1656.
2004.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Pereira LMS, Gomes STM, Ishak R and
Vallinoto ACR: Regulatory T Cell and forkhead box protein 3 as
modulators of immune homeostasis. Front Immunol.
8(605)2017.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Gao L, Li K, Li F, Li H, Liu L, Wang L,
Zhang Z, Gao T and Liu Y: Polymorphisms in the FOXP3 gene in Han
Chinese psoriasis patients. J Dermatol Sci. 57:51–56.
2010.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Oda JMm, Hirata BKb, Guembarovski RL and
Watanabe MAe: Genetic polymorphism in FOXP3 gene: Imbalance in
regulatory T-cell role and development of human diseases. J Genet.
92:163–171. 2013.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Goronzy JJ, Zettl A and Weyand CM: T cell
receptor repertoire in rheumatoid arthritis. Int Rev Immunol.
17:339–363. 1998.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Nordquist H and Jamil RT: Biochemistry,
HLA antigens. In: StatPearls [Internet]. Treasure Island (FL):
StatPearls Publishing, 2025.
|
|
119
|
Wysocki T, Olesińska M and
Paradowska-Gorycka A: Current understanding of an emerging role of
HLA-DRB1 gene in rheumatoid arthritis-from research to clinical
practice. Cells. 9(1127)2020.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Ota H and Igarashi S: Expression of major
histocompatibility complex class II antigen in endometriotic tissue
in patients with endometriosis and adenomyosis. Fertil Steril.
60:834–838. 1993.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Capon F: The genetic basis of psoriasis.
Int J Mol Sci. 18(2526)2017.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Griffiths CE and Barker JN: Pathogenesis
and clinical features of psoriasis. Lancet. 370:263–271.
2007.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Zong W, Ge Y, Han Y, Yang X, Li Q and Chen
M: Hypomethylation of HLA-DRB1 and its clinical significance in
psoriasis. Oncotarget. 8:12323–12332. 2017.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Chong WP, Ip WK, Wong WHS, Lau CS, Chan TM
and Lau YL: Association of interleukin-10 promoter polymorphisms
with systemic lupus erythematosus. Genes Immun. 5:484–492.
2004.PubMed/NCBI View Article : Google Scholar
|
|
125
|
Döcke WD, Asadullah K, Belbe G, Ebeling M,
Höflich C, Friedrich M, Sterry W and Volk HD: Comprehensive
biomarker monitoring in cytokine therapy: Heterogeneous,
time-dependent, and persisting immune effects of interleukin-10
application in psoriasis. J Leukoc Biol. 85:582–593.
2009.PubMed/NCBI View Article : Google Scholar
|
|
126
|
Tedgui A and Mallat Z: Interleukin-10: An
anti-atherogenic cytokine. Pathol Biol (Paris). 49:107–108.
2001.PubMed/NCBI View Article : Google Scholar : (In French).
|
|
127
|
de Waal Malefyt R, Abrams J, Bennett B,
Figdor CG and de Vries JE: Interleukin 10(IL-10) inhibits cytokine
synthesis by human monocytes: An autoregulatory role of IL-10
produced by monocytes. J Exp Med. 174:1209–1220. 1991.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Groux H and Cottrez F: The complex role of
interleukin-10 in autoimmunity. J Autoimmun. 20:281–285.
2003.PubMed/NCBI View Article : Google Scholar
|
|
129
|
Liaqat I, Jahan N, Lone KP, Pakstis A and
Taylor HS: Genetic polymorphisms associated with endometriosis in
Pakistani women. J Endometr Pelvic Pain Disord. 5:134–143.
2013.
|
|
130
|
Edwards-Smith CJ, Jonsson JR, Purdie DM,
Bansal A, Shorthouse C and Powell EE: Interleukin-10 promoter
polymorphism predicts initial response of chronic hepatitis C to
interferon alfa. Hepatology. 30:526–530. 1999.PubMed/NCBI View Article : Google Scholar
|
|
131
|
Zhang X, Hei P, Deng L and Lin J:
Interleukin-10 gene promoter polymorphisms and their protein
production in peritoneal fluid in patients with endometriosis. Mol
Hum Reprod. 13:135–140. 2007.PubMed/NCBI View Article : Google Scholar
|
|
132
|
Goyette P, Pai A, Milos R, Frosst P, Tran
P, Chen Z, Chan M and Rozen R: Gene structure of human and mouse
methylenetetrahydrofolate reductase (MTHFR). Mamm Genome.
9:652–656. 1998.PubMed/NCBI View Article : Google Scholar
|
|
133
|
Watkins D and Rosenblatt DS: Inherited
disorders of folate and cobalamin transport and Metabolism. In: The
Online Metabolic and Molecular Bases of Inherited Disease. Valle
DL, Antonarakis S, Ballabio A, Beaudet AL and Mitchell GA (eds).
McGraw-Hill Education, New York, NY, 2019.
|
|
134
|
Qi J, Zhang Y, Zhang L and Nie G:
Association between the MTHFR 677C/T polymorphism and
susceptibility to psoriasis: An updated meta-analysis. Res Sq,
2022.
|
|
135
|
Frosst P, Blom HJ, Milos R, Goyette P,
Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA,
van den Heuvel LP, et al: A candidate genetic risk factor for
vascular disease: A common mutation in methylenetetrahydrofolate
reductase. Nat Genet. 10:111–113. 1995.PubMed/NCBI View Article : Google Scholar
|
|
136
|
van der Put NM, Gabreëls F, Stevens EM,
Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP and Blom HJ:
A second common mutation in the methylenetetrahydrofolate reductase
gene: an additional risk factor for neural-tube defects? Am J Hum
Genet. 62:1044–1051. 1998.PubMed/NCBI View
Article : Google Scholar
|
|
137
|
Sharp L and Little J: Polymorphisms in
genes involved in folate metabolism and colorectal neoplasia: A
HuGE review. Am J Epidemiol. 159:423–443. 2004.PubMed/NCBI View Article : Google Scholar
|
|
138
|
Lu M, Peng K, Song L, Luo L, Liang P and
Liang Y: Association between genetic polymorphisms in
methylenetetrahydrofolate reductase and risk of autoimmune
diseases: A systematic review and meta-analysis. Dis Markers.
2022(4568145)2022.PubMed/NCBI View Article : Google Scholar
|
|
139
|
Zervou MI, Papageorgiou L, Vlachakis D,
Spandidos DA, Eliopoulos E and Goulielmos GN: Genetic factors
involved in the co-occurrence of endometriosis with ankylosing
spondylitis (review). Mol Med Rep. 27(96)2023.PubMed/NCBI View Article : Google Scholar
|
|
140
|
Luo Q, Zeng J, Li W, Lin L, Zhou X, Tian
X, Liu W, Zhang L and Zhang X: Interaction of MTHFR gene with
smoking and alcohol use and haplotype combination susceptibility to
psoriasis in Chinese population. Immunol Res. 66:543–547.
2018.PubMed/NCBI View Article : Google Scholar
|
|
141
|
Huraib GB, Harthi FA, Arfin M, Khlaiwi AA,
Rizvi S and Al-Asmari A: Methylenetetrahydrofolate reductase C677T
gene polymorphism as risk factor for psoriasis in Saudis. Biomark
Insights. 14(1177271919830973)2019.PubMed/NCBI View Article : Google Scholar
|
|
142
|
Karabacak E, Aydin E, Ozcan O, Dogan B,
Gultepe M, Cosar A and Muftuoglu T: Methylenetetrahydrofolate
reductase (MTHFR) 677C>T gene polymorphism as a possible factor
for reducing clinical severity of psoriasis. Int J Clin Exp Med.
7:697–702. 2014.PubMed/NCBI
|
|
143
|
Wu D, Shi D, Yang L and Zhu X: Association
between methylenetetrahydrofolate reductase C677T polymorphism and
psoriasis: A meta-analysis. J Dermatol. 43:162–169. 2016.PubMed/NCBI View Article : Google Scholar
|
|
144
|
Zamani MR, Salmaninejad A, Akbari Asbagh
F, Masoud A and Rezaei N: STAT4 single nucleotide gene
polymorphisms and susceptibility to endometriosis-related
infertility. Eur J Obstet Gynecol Reprod Biol. 203:20–24.
2016.PubMed/NCBI View Article : Google Scholar
|
|
145
|
Frucht DM, Aringer M, Galon J, Danning C,
Brown M, Fan S, Centola M, Wu CY, Yamada N, El Gabalawy H and
O'Shea JJ: Stat4 is expressed in activated peripheral blood
monocytes, dendritic cells, and macrophages at sites of
Th1-mediated inflammation. J Immunol. 164:4659–4664.
2000.PubMed/NCBI View Article : Google Scholar
|
|
146
|
Mathur AN, Chang HC, Zisoulis DG,
Stritesky GL, Yu Q, O'Malley JT, Kapur R, Levy DE, Kansas GS and
Kaplan MH: Stat3 and Stat4 direct development of IL-17-secreting Th
cells. J Immunol. 178:4901–4907. 2007.PubMed/NCBI View Article : Google Scholar
|
|
147
|
Thierfelder WE, van Deursen JM, Yamamoto
K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DA,
Doherty PC, Grosveld GC and Ihle JN: Requirement for Stat4 in
interleukin-12-mediated responses of natural killer and T cells.
Nature. 382:171–174. 1996.PubMed/NCBI View Article : Google Scholar
|
|
148
|
Wun CM, Piao Z, Hong KT, Choi JY, Hong CR,
Park JD, Park KD, Shin HY and Kang HJ: Effect of donor STAT4
polymorphism rs7574865 on clinical outcomes of pediatric acute
leukemia patients after hematopoietic stem cell transplant. Int
Immunopharmacol. 43:62–69. 2017.PubMed/NCBI View Article : Google Scholar
|
|
149
|
Zervou MI, Mamoulakis D, Panierakis C,
Boumpas DT and Goulielmos GN: STAT4: A risk factor for type 1
diabetes? Hum Immunol. 69:647–650. 2008.PubMed/NCBI View Article : Google Scholar
|
|
150
|
Podgaec S, Dias Junior JA, Chapron C, de
Oliveira RM, Baracat EC and Abrão MS: Th1 and Th2 immune responses
related to pelvic endometriosis. Rev Assoc Med Bras (1992).
56:92–98. 2010.PubMed/NCBI View Article : Google Scholar
|
|
151
|
Remmers EF, Plenge RM, Lee AT, Graham RR,
Hom G, Behrens TW, de Bakker PIW, Le JM, Lee HS, Batliwalla F, et
al: STAT4 and the risk of rheumatoid arthritis and systemic lupus
erythematosus. N Engl J Med. 357:977–986. 2007.PubMed/NCBI View Article : Google Scholar
|
|
152
|
Li B, Huang L, Lv P, Li X, Liu G, Chen Y,
Wang Z, Qian X, Shen Y, Li Y and Fang W: The role of Th17 cells in
psoriasis. Immunol Res. 68:296–309. 2020.PubMed/NCBI View Article : Google Scholar
|
|
153
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676.
2003.PubMed/NCBI View Article : Google Scholar
|
|
154
|
Girling JE and Rogers PA: Recent advances
in endometrial angiogenesis research. Angiogenesis. 8:89–99.
2005.PubMed/NCBI View Article : Google Scholar
|
|
155
|
Pandey AK, Singhi EK, Arroyo JP, Ikizler
TA, Gould ER, Brown J, Beckman JA, Harrison DG and Moslehi J:
Mechanisms of VEGF (vascular endothelial growth factor)
inhibitor-associated hypertension and vascular disease.
Hypertension. 71:e1–e8. 2018.PubMed/NCBI View Article : Google Scholar
|
|
156
|
Fukumura D, Xavier R, Sugiura T, Chen Y,
Park EC, Lu N, Selig M, Nielsen G, Taksir T, Jain RK and Seed JB:
Tumor induction of VEGF promoter activity in stromal cells. Cell.
94:715–725. 1998.PubMed/NCBI View Article : Google Scholar
|
|
157
|
Bhanoori M, Arvind Babu K, Pavankumar
Reddy NG, Lakshmi Rao K, Zondervan K, Deenadayal M, Kennedy S and
Shivaji S: The vascular endothelial growth factor (VEGF) +405G>C
5'-untranslated region polymorphism and increased risk of
endometriosis in South Indian women: A case control study. Hum.
Reprod. 20:1844–1849. 2005.PubMed/NCBI View Article : Google Scholar
|
|
158
|
Li YZ, Wang LJ, Li X, Li SL, Wang JL, Wu
ZH, Gong L and Zhang XD: Vascular endothelial growth factor gene
polymorphisms contribute to the risk of endometriosis: An updated
systematic review and meta-analysis of 14 case-control studies.
Genet Mol Res. 12:1035–1044. 2013.PubMed/NCBI View Article : Google Scholar
|
|
159
|
Buroker NE: SNP (rs1570360) in
transcriptional factor binding sites of the VEGFA promoter is
associated with hypertensive nephropathy and diabetic retinopathy.
Austin J Endocrinol Diabetes. 2(1035)2015.
|
|
160
|
Tan XJ, Lang JH, Liu DY, Shen K, Leng JH
and Zhu L: Expression of vascular endothelial growth factor and
thrombospondin-1 mRNA in patients with endometriosis. Fertil
Steril. 78:148–153. 2002.PubMed/NCBI View Article : Google Scholar
|
|
161
|
Cosín R, Gilabert-Estellés J, Ramón LA,
Gómez-Lechón MJ, Gilabert J, Chirivella M, Braza-Boïls A, España F
and Estellés A: Influence of peritoneal fluid on the expression of
angiogenic and proteolytic factors in cultures of endometrial cells
from women with endometriosis. Hum Reprod. 25:398–405.
2010.PubMed/NCBI View Article : Google Scholar
|
|
162
|
Donnez J, Smoes P, Gillerot S,
Casanas-Roux F and Nisolle M: Vascular endothelial growth factor
(VEGF) in endometriosis. Hum Reprod. 13:1686–1690. 1998.PubMed/NCBI View Article : Google Scholar
|
|
163
|
McLaren J: Vascular endothelial growth
factor and endometriotic angiogenesis. Hum Reprod Update. 6:45–55.
2000.PubMed/NCBI View Article : Google Scholar
|
|
164
|
Viganò P, Parazzini F, Somigliana E and
Vercellini P: Endometriosis: Epidemiology and aetiological factors.
Best Pract Res Clin Obstet Gynaecol. 18:177–200. 2004.PubMed/NCBI View Article : Google Scholar
|
|
165
|
Cox A, Camp NJ, Nicklin MJ, di Giovine FS
and Duff GW: An analysis of linkage disequilibrium in the
interleukin-1 gene cluster, using a novel grouping method for
multiallelic markers. Am J Hum Genet. 62:1180–1188. 1998.PubMed/NCBI View Article : Google Scholar
|
|
166
|
Johnson K, Hashimoto S, Lotz M, Pritzker K
and Terkeltaub R: Interleukin-1 induces pro-mineralizing activity
of cartilage tissue transglutaminase and factor XIIIa. Am J Pathol.
159:149–163. 2001.PubMed/NCBI View Article : Google Scholar
|
|
167
|
Badie A, Saliminejad K, Salahshourifar I
and Khorram Khorshid HR: Interleukin 1 alpha (IL1A) polymorphisms
and risk of endometriosis in Iranian population: a case-control
study. Gynecol Endocrinol. 36:135–138. 2020.PubMed/NCBI View Article : Google Scholar
|
|
168
|
Sikora J, Ferrero S, Mielczarek-Palacz A
and Kondera-Anasz Z: The delicate balance between the good and the
bad IL-1 proinflammatory effects in endometriosis. Curr Med Chem.
25:2105–2121. 2018.PubMed/NCBI View Article : Google Scholar
|
|
169
|
Kondera-Anasz Z, Sikora J,
Mielczarek-Palacz A and Jońca M: Concentrations of interleukin
(IL)-1alpha, IL-1 soluble receptor type II (IL-1 sRII) and IL-1
receptor antagonist (IL-1 Ra) in the peritoneal fluid and serum of
infertile women with endometriosis. Eur J Obstet Gynecol Reprod
Biol. 123:198–203. 2005.PubMed/NCBI View Article : Google Scholar
|
|
170
|
Koumantakis E, Matalliotakis I, Neonaki M,
Froudarakis G and Georgoulias V: Soluble serum interleukin-2
receptor, interleukin-6 and interleukin-1a in patients with
endometriosis and in controls. Arch Gynecol Obstet. 255:107–112.
1994.PubMed/NCBI View Article : Google Scholar
|
|
171
|
Nackley AG, Shabalina SA, Tchivileva IE,
Satterfield K, Korchynskyi O, Makarov SS, Maixner W and Diatchenko
L: Human catechol-O-methyltransferase haplotypes modulate protein
expression by altering mRNA secondary structure. Science.
314:1930–1933. 2006.PubMed/NCBI View Article : Google Scholar
|
|
172
|
Graves BJ, Hatada MH, Hendrickson WA,
Miller JK, Madison VS and Satow Y: Structure of interleukin 1 alpha
at 2.7-A resolution. Biochemistry. 29:2679–2684. 1990.PubMed/NCBI View Article : Google Scholar
|
|
173
|
Adzhubei IA, Schmidt S, Peshkin L,
Ramensky VE, Gerasimova A, Bork P, Kondrashov AS and Sunyaev SR: A
method and server for predicting damaging missense mutations. Nat
Methods. 7:248–249. 2010.PubMed/NCBI View Article : Google Scholar
|
|
174
|
Partsch G, Steiner G, Leeb BF, Dunky A,
Bröll H and Smolen JS: Highly increased levels of tumor necrosis
factor-alpha and other proinflammatory cytokines in psoriatic
arthritis synovial fluid. J Rheumatol. 24:518–523. 1997.PubMed/NCBI
|
|
175
|
Ritchlin C, Haas-Smith SA, Hicks D,
Cappuccio J, Osterland CK and Looney RJ: Patterns of cytokine
production in psoriatic synovium. J Rheumatol. 25:1544–1552.
1998.PubMed/NCBI
|
|
176
|
Donn R, Alourfi Z, De Benedetti F, Meazza
C, Zeggini E, Lunt M, Stevens A, Shelley E, Lamb R, Ollier WER, et
al: Mutation screening of the macrophage migration inhibitory
factor gene: positive association of a functional polymorphism of
macrophage migration inhibitory factor with juvenile idiopathic
arthritis. Arthritis Rheum. 46:2402–2409. 2002.PubMed/NCBI View Article : Google Scholar
|
|
177
|
Calandra T and Roger T: Macrophage
migration inhibitory factor: A regulator of innate immunity. Nat
Rev Immunol. 3:791–800. 2003.PubMed/NCBI View Article : Google Scholar
|
|
178
|
Bacher M, Metz CN, Calandra T, Mayer K,
Chesney J, Lohoff M, Gemsa D, Donnelly T and Bucala R: An essential
regulatory role for macrophage migration inhibitory factor in
T-cell activation. Proc Natl Acad Sci USA. 93:7849–7854.
1996.PubMed/NCBI View Article : Google Scholar
|
|
179
|
Denkinger CM, Metz C, Fingerle-Rowson G,
Denkinger MD and Forsthuber T: Macrophage migration inhibitory
factor and its role in autoimmune diseases. Arch Immunol Ther Exp
(Warsz). 52:389–400. 2004.PubMed/NCBI
|
|
180
|
Kats R, Metz CN and Akoum A: Macrophage
migration inhibitory factoris markedly expressed in active and
early-stage endometriotic lesions. J Clin Endocrinol Metab.
87:883–889. 2002.PubMed/NCBI View Article : Google Scholar
|
|
181
|
Veillat V, Sengers V, Metz CN, Roger T,
Leboeuf M, Mailloux J and Akoum A: Macrophage migration inhibitory
factor is involved in a positive feedback loop increasing aromatase
expression in endometriosis. Am J Pathol. 181:917–927.
2012.PubMed/NCBI View Article : Google Scholar
|
|
182
|
Cloutier JF and Veillette A: Cooperative
inhibition of T-cell antigen receptor signaling by a complex
between a kinase and a phosphatase. J Exp Med. 189:111–121.
1999.PubMed/NCBI View Article : Google Scholar
|
|
183
|
Wu J, Katrekar A, Honigberg LA, Smith AM,
Conn MT, Tang J, Jeffery D, Mortara K, Sampang J, Williams SR, et
al: Identification of substrates of human protein-tyrosine
phosphatase PTPN22. J Biol Chem. 281:11002–11010. 2006.PubMed/NCBI View Article : Google Scholar
|
|
184
|
Juneblad K, Johansson M,
Rantapää-Dahlqvist S and Alenius GM: Association between the PTPN22
+1858 C/T polymorphism and psoriatic arthritis. Arthritis Res Ther.
13(R45)2011.PubMed/NCBI View
Article : Google Scholar
|
|
185
|
Kotlyar AM, Mamillapalli R, Flores VA and
Taylor HS: Tofacitinib alters STAT3 signaling and leads to
endometriosis lesion regression. Mol Hum Reprod.
27(gaab016)2021.PubMed/NCBI View Article : Google Scholar
|
|
186
|
Abisror N, Kolanska K, Cheloufi M,
Selleret L, d'Argent E, Kayem G and Mekinian A: Endometriosis and
autoimmunity. Explor Immunol. 2:25–31. 2022.
|
|
187
|
Gaffen SL, Jain R, Garg AV and Cua DJ: The
IL-23-IL-17 immune axis: From mechanisms to therapeutic testing.
Nat Rev Immunol. 14:585–600. 2014.PubMed/NCBI View Article : Google Scholar
|
|
188
|
Tian F, Chen Z and Xu T: Efficacy and
safety of tofacitinib for the treatment of chronic plaque
psoriasis: A systematic review and meta-analysis. J Int Med Res.
47:2342–2350. 2019.PubMed/NCBI View Article : Google Scholar
|
|
189
|
Ighani A, Georgakopoulos JR and Yeung J:
Tofacitinib for the treatment of psoriasis and psoriatic arthritis.
G Ital Dermatol Venereol. 155:400–410. 2020.PubMed/NCBI View Article : Google Scholar
|
|
190
|
Hu X, Li J, Fu M, Zhao X and Wang W: The
JAK/STAT signaling pathway: From bench to clinic. Signal Transduct
Target Ther. 6(402)2021.PubMed/NCBI View Article : Google Scholar
|
|
191
|
Falconer H, Sundqvist J,
Gemzell-Danielsson K, von Schoultz B, D'Hooghe TM and Fried G: IVF
outcome in women with endometriosis in relation to tumour necrosis
factor and anti-Müllerian hormone. Reprod Biomed Online.
18:582–588. 2009.PubMed/NCBI View Article : Google Scholar
|
|
192
|
Gisondi P and Girolomoni G: Biologic
therapies in psoriasis: A new therapeutic approach. Autoimmun Rev.
6:515–519. 2007.PubMed/NCBI View Article : Google Scholar
|
|
193
|
Mease PJ, Goffe BS, Metz J, Van der Stoep
A, Finck B and Burge DJ: Etanercept in the treatment of psoriatic
arthritis and psoriasis: A randomised trial. Lancet. 356:385–390.
2000.PubMed/NCBI View Article : Google Scholar
|
|
194
|
Braun DP, Ding J and Dmowski WP:
Peritoneal fluid-mediated enhancement of eutopic and ectopic
endometrial cell proliferation is dependent on tumor necrosis
factor-alpha in women with endometriosis. Fertil Steril.
78:727–732. 2002.PubMed/NCBI View Article : Google Scholar
|
|
195
|
D'Angelo S, Cantini F, Ramonda R,
Cantarini L, Carletto A, Chimenti MS, Delle Sedie A, Foti R, Gerli
R, Lomater C, et al: Effectiveness of adalimumab for the treatment
of psoriatic arthritis: An Italian real-life retrospective study.
Front Pharmacol. 10(1497)2019.PubMed/NCBI View Article : Google Scholar
|
|
196
|
Calabrese LH: Molecular differences in
anticytokine therapies. Clin Exp Rheumatol. 21:241–248.
2003.PubMed/NCBI
|
|
197
|
Alwawi EA, Mehlis SL and Gordon KB:
Treating psoriasis with adalimumab. Ther Clin Risk Manag.
4:345–351. 2008.PubMed/NCBI View Article : Google Scholar
|
|
198
|
Kaplan S, Kırıcı P and Türk A: The effects
of adalimumab on the rat autotransplantation endometriosis model: A
placebo-controlled randomized study. Adv Clin Exp Med. 31:417–426.
2022.PubMed/NCBI View Article : Google Scholar
|
|
199
|
Ahn SH, Khalaj K, Young SL, Lessey BA,
Koti M and Tayade C: Immune-inflammation gene signatures in
endometriosis patients. Fertil Steril. 106:1420–1431.e7.
2016.PubMed/NCBI View Article : Google Scholar
|
|
200
|
Szóstek-Mioduchowska A, Wójtowicz A,
Sadowska A, Moza Jalali B, Słyszewska M, Łukasik K, Gurgul A,
Szmatoła T, Bugno-Poniewierska M, Ferreira-Dias G and Skarzynski
DJ: Transcriptomic profiling of mare endometrium at different
stages of endometrosis. Sci Rep. 13(16263)2023.PubMed/NCBI View Article : Google Scholar
|
|
201
|
Liu S, Li X, Gu Z, Wu J, Jia S, Shi J, Dai
Y, Wu Y, Yan H, Zhang J, et al: Single-cell and spatial
transcriptomic profiling revealed niche interactions sustaining
growth of endometriotic lesions. Cell Genom.
5(100737)2025.PubMed/NCBI View Article : Google Scholar
|
|
202
|
Burns GW, Fu Z, Vegter EL, Madaj ZB,
Greaves E, Flores I and Fazleabas AT: Spatial transcriptomic
analysis identifies epithelium-macrophage crosstalk in
endometriotic lesions. iScience. 28(111790)2025.PubMed/NCBI View Article : Google Scholar
|
|
203
|
Swindell WR, Johnston A, Voorhees JJ,
Elder JT and Gudjonsson JE: Dissecting the psoriasis transcriptome:
Inflammatory- and cytokine-driven gene expression in lesions from
163 patients. BMC Genomics. 14(527)2013.PubMed/NCBI View Article : Google Scholar
|
|
204
|
Choudhary S, Anand R, Pradhan D, Bastia B,
Kumar SN, Singh H, Puri P, Thomas G and Jain AK: Transcriptomic
landscaping of core genes and pathways of mild and severe psoriasis
vulgaris. Int J Mol Med. 47:219–231. 2021.PubMed/NCBI View Article : Google Scholar
|
|
205
|
Rawat A, Rinchai D, Toufiq M, Marr AK,
Kino T, Garand M, Tatari-Calderone Z, Kabeer BSA, Krishnamoorthy N,
Bedognetti D, et al: A Neutrophil-driven inflammatory signature
characterizes the blood transcriptome fingerprint of psoriasis.
Front Immunol. 11(587946)2020.PubMed/NCBI View Article : Google Scholar
|
|
206
|
Garshick MS, Barrett TJ, Cornwell MG,
Drenkova K, Garelik J, Weber BN, Schlamp F, Rockman C, Ruggles KV,
Reynolds HR and Berger JS: An inflammatory transcriptomic signature
in psoriasis associates with future cardiovascular events. J Eur
Acad Dermatol Venereol. 37:1361–1365. 2023.PubMed/NCBI View Article : Google Scholar
|
|
207
|
Krishnan VS and Kõks S: Transcriptional
basis of psoriasis from large scale gene expression studies: The
importance of moving towards a precision medicine approach. Int J
Mol Sci. 23(6130)2022.PubMed/NCBI View Article : Google Scholar
|
|
208
|
Rioux G, Ridha Z, Simard M, Turgeon F,
Guérin SL and Pouliot R: Transcriptome profiling analyses in
psoriasis: A dynamic contribution of keratinocytes to the
pathogenesis. Genes (Basel). 11(1155)2020.PubMed/NCBI View Article : Google Scholar
|
|
209
|
Laborde CM, Larzabal L, González-Cantero
Á, Castro-Santos P and Díaz-Peña R: Advances of genomic medicine in
psoriatic arthritis. J Pers Med. 12(35)2022.PubMed/NCBI View Article : Google Scholar
|
|
210
|
Johnsson H, Cole J, McInnes IB, Graham G
and Siebert S: Differences in transcriptional changes in psoriasis
and psoriatic arthritis skin with immunoglobulin gene enrichment in
psoriatic arthritis. Rheumatology (Oxford). 63:218–225.
2024.PubMed/NCBI View Article : Google Scholar
|
|
211
|
Grivas A, Grigoriou M, Malissovas N,
Sentis G, Filia A, Flouda S, Katsimpri P, Verginis P and Boumpas
DT: Combined-whole blood and skin fibroblasts-transcriptomic
analysis in psoriatic arthritis reveals molecular signatures of
activity, resistance and early response to treatment. Front
Immunol. 13(964274)2022.PubMed/NCBI View Article : Google Scholar
|
|
212
|
Grivas A, Fragoulis G, Garantziotis P,
Banos A, Nikiphorou E and Boumpas D: Unraveling the complexities of
psoriatic arthritis by the use of-Omics and their relevance for
clinical care. Autoimmun Rev. 20(102949)2021.PubMed/NCBI View Article : Google Scholar
|
|
213
|
Ding J, Su S, You T, Xia T, Lin X, Chen Z
and Zhang L: Serum interleukin-6 level is correlated with the
disease activity of systemic lupus erythematosus: A meta-analysis.
Clinics (Sao Paulo). 75(e1801)2020.PubMed/NCBI View Article : Google Scholar
|
|
214
|
Atzeni F, Ventura D, Batticciotto A,
Boccassini L and Sarzi-Puttini P: Interleukin 6 blockade:
tocilizumab in psoriatic arthritis. J Rheumatol Suppl. 89:97–99.
2012.PubMed/NCBI View Article : Google Scholar
|
|
215
|
Costa L, Caso F, Cantarini L, Del Puente
A, Scarpa R and Atteno M: Efficacy of tocilizumab in a patient with
refractory psoriatic arthritis. Clin Rheumatol. 33:1355–1357.
2014.PubMed/NCBI View Article : Google Scholar
|
|
216
|
Hayakawa M, Izumi K, Higashida-Konishi M,
Ushikubo M, Tsukamoto M, Akiya K, Araki K and Oshima H:
Tocilizumab-induced psoriasis-like eruption resolved by shortening
the dose interval in a patient with rheumatoid arthritis: A
case-based review. Rheumatol Int. 39:161–166. 2019.PubMed/NCBI View Article : Google Scholar
|
|
217
|
Nielly H, Bialé L, Gilardin L, Carmoi T,
Éon A, Vanquaethem H and Fougerousse AC: Tocilizumab-induced
psoriatic eruption: A case report and a case-based review.
Rheumatol Int. 44:2205–2212. 2024.PubMed/NCBI View Article : Google Scholar
|
|
218
|
Papageorgiou L, Andreou A, Zervou M,
Vlachakis D, Goulielmos GN and Eliopoulos E: A global population
genomic analysis shows novel insights into the genetic
characteristics of endometriosis. World Acad Sci J. 5(12)2023.
|
|
219
|
Oliveros JC: Venny. An interactive tool
for comparing lists with Venn's diagrams, 2007-2015. https://bioinfogp.cnb.csic.es/tools/venny/index.html.
|
